Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid significant developments including the approval of its acquisition of …
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced significant progress in expanding access to its NeuroStar TMS Therapy for patients with major depressive disorder (MDD).
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced significant enhancements to its NeuroStar Advanced Therapy and TrakStar® software, aiming to improve patient care and strengthen data management. These updates introduce …
Neuronetics Enhances NeuroStar Therapy with New Features Read More
MALVERN, PA — In recognition of Suicide Prevention Month, Neuronetics, Inc. (NASDAQ: STIM) is spotlighting the impactful stories shared on its NeuroStar Voices Portal. This platform, launched last year, allows individuals …
Neuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide Rates Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently celebrated the two-year anniversary of NeuroStar University (NSU) with a special event at their training center in Charlotte, North Carolina. This milestone highlighted …
Neuronetics Celebrates Two Years of NeuroStar University Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its financial and operational results for the second quarter of 2024, marking a period of strategic initiatives and significant developments in …
Neuronetics Reports Second Quarter 2024 Financial Results and Strategic Developments Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) have announced a definitive arrangement, wherein Neuronetics will acquire all outstanding common shares of Greenbrook in an …
Neuronetics Acquires Greenbrook TMS, Enhancing Mental Health Care Delivery Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced a partnership with the non-profit organization This Is My Brave to support Teen Mental Health Month in August. This collaboration aims …
Neuronetics Partners with This Is My Brave for Teen Mental Health Month Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Aetna has updated its coverage policy for transcranial magnetic stimulation (TMS) to include adolescents aged 15 and older with major depressive …
Aetna Expands TMS Coverage to Adolescents with Major Depressive Disorder Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that California Medicaid, known as Medi-Cal, will now cover transcranial magnetic stimulation (TMS) for both adults and adolescents aged 15 and older …
Neuronetics Secures Medi-Cal Coverage for TMS Treatment in California Read More